- Acquired by Dilon Technologies, Apr 2020
- Raised $12.3M Series D led by ATON Partners, Jun 2017
- Raised $21M Series C led by Apax Partners, Sep 2014
About
Dune Medical Devices has developed tissue characterization technology that can be used for a broad range of diagnostic and therapeutic applications and offers surgeons and radiologists the ability to detect cancer in real time. The company's MarginProbe System delivers real-time cancer detection in the operating room through a simple assessment of the margin of excised tissue. The key element of the MarginProbe System is its Fringe Field Sensor. Positioned at the tip of the probe, the highly responsive sensor emits a precisely controlled electromagnetic field and captures the tissue's response. The sensor identifies signals in close range to the edge of the tissue, the critical focus of margin assessment. The company is also developing a smart biopsy system. The system will expand the company's surgical oncology portfolio to include a soft tissue biopsy system with its first indication in breast tissue. This project has received funding from the European Union's Horizon 2020 research and innovation program.
Funding history · 6 rounds · $53.8M total
Headcount over time
Q&A
- What is Dune Medical Devices' primary focus?
- Dune Medical Devices developed tissue characterization technology for real-time cancer detection during surgery, specifically with its MarginProbe System for breast cancer.
- When was Dune Medical Devices acquired and by whom?
- Dune Medical Devices was acquired by Dilon Technologies in April 2020.
- What was the total amount of funding raised by Dune Medical Devices?
- Dune Medical Devices raised a total of $57,075,100 in funding.
- What is the employee count for Dune Medical Devices?
- Dune Medical Devices has 11-50 employees.
- What is the MarginProbe System?
- The MarginProbe System is Dune Medical Devices' technology that provides real-time cancer detection in the operating room by assessing the margin of excised tissue using a Fringe Field Sensor.
- What other product is Dune Medical Devices developing?
- Dune Medical Devices is developing a smart biopsy system to expand its surgical oncology portfolio, with a first indication in breast tissue. This project received funding from the European Union's Horizon 2020 program.
- Where are Dune Medical Devices' headquarters located?
- Dune Medical Devices' headquarters are located in Caesarea, Israel, with an additional office in Alpharetta, USA.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | dunemedical.com |
|---|---|
| linkedin.com/company/80980 | |
| facebook.com/marginprobe | |
| YouTube | youtube.com/channel/UCSHOZXTrhOjiqQgWrhVp7-A |
Identifiers & details
| Founded | 2002-1 |
|---|---|
| Employees (exact) | 30 |
| Offices | Alpharetta |
| Status reason | Acquired (Inactive) by Dilon Technologies on Apr 2020 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Dilon Technologies 2020-04
Radar intelligence
Patents
| EPO | 35 |
|---|
Web history (Wayback)
| Domain | dunemedical.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513172247 |
|---|---|
| Status | חיסול ע~י בימ~ש — CLOSED |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2001-12-05 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2018 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | אלון התבור 20 קיסריה |